Sort by
Refine Your Search
-
(2025), Science Advances (2024), Nature Communications (2024), PLOS Biology ( 2024), Cell (2024), Developmental Cell (2023, 2010, 2011). Prof. Wang, an EMBO Associate Member, is an internationally
-
opportunities for travel to Tanzania. Role Summary Work with the study investigators (Prof. Sam Watson (University of Birmingham), Dr Penelope Hancock (Imperial College London) and Prof. Fredros Okumu (University
-
crystallisation-driven self-assembly of polyester-based block polymers. The project will be hosted in the group of Prof. Rachel O’Reilly in the School of Chemistry. The post holder will be responsible
-
Chemistry groups led by Prof. Peter Slater, Professor Paul Anderson, and Dr. Phoebe Allan, https://www.birmingham.ac.uk/staff/profiles/chemistry/anderson-paul.aspx https://www.birmingham.ac.uk/staff/profiles
-
progression once in post to £48,149 Grade: 7 Full Time, Fixed Term contract up to March 2028 Closing date: 13th August 2025 Background This research project aims to establish the theoretical and algorithmic
-
The research group of Prof. Dr. Nikolaos Perakakis is seeking for a highly motivated and talented Postdoctoral Research Fellow (max. 6 years from the acquisition of the doctoral degree) to join our
-
. Develop research objectives and proposals for own or joint research, in the area of interest of the hosting laboratory (Prof. T. Carlomagno) Contribute to writing bids for research funding Acquire, analyse
-
Call for Outstanding Global Postdoctoral Fellows in the Biomaterials and Regenerative Medicine Group
Join the Biomaterials and Regenerative Medicine Group at SCUT! About Us Welcome to the Biomaterials and Regenerative Medicine Group, led by Prof. Liming Bian! We are a dynamic, international
-
part of the DECODE-PD research group (led by Prof. Charalampos Tzoulis) in collaboration with the Cell Fate Lab (led by Prof. Simona Chera). About the project/work tasks The postdoctoral fellow will be
-
Senior Postdoctoral / Research Associate position (100%) in the Molecular Oncology Group Directed by Prof. Andrea Alimonti at the IOR - Institute of Oncology Research in Bellinzona, Switzerland